Dose-Dependent Preventive Effect of Saccharomyces boulardii on clindamycin-induced Alterations in Intestinal Aerobic Flora of the Hamster

Microbial Ecology in Health and Disease

Volumn 15, Issue 2-3, 2003, Pages 126-130

  Philippe Taine, Géraldine ^a   Coroler, Loic ^a   Levy, René H ^b   Gillardin, Jean Marie ^a  

^a Service de Pharmacologie   (France)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Antibiotic associated diarrhoea; Clindamycin; Hamster; Intestinal microflora; Saccharomyces boulardii

Indexed keywords

CLINDAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC ASSOCIATED DIARRHEA; ANTIBIOTIC THERAPY; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DIARRHEA; DRUG INDUCED DISEASE; ECOSYSTEM; HAMSTER; INTESTINE FLORA; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; REPRODUCIBILITY; SACCHAROMYCES BOULARDII; STRAIN DIFFERENCE; SURVIVAL;

ANIMALIA; CANDIDA; CRICETINAE; ENTEROBACTERIACEAE; MESOCRICETUS AURATUS; SACCHAROMYCES; SACCHAROMYCES BOULARDII;

EID: 0345095392     PISSN: 0891060X     EISSN: None     Source Type: Journal    
DOI: 10.1080/08910600310015998     Document Type: Article

References (15)

1. Klein SM, Elmer GW, McFarland LV, Surawicz CM, Levy RH. Recovery and elimination of the biotherapeutic agent, Saccharomyces boulardii, in healthy human volunteers. Pharm Res 1993; 10: 1615-9.
2. Surawicz CM, McFarland LV, Greenberg RN, Rubin M, Fekety R, Mulligan ME, Garcia RJ, Brandmarker S, Bowen K, Borjal D, Elmer GW. The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. Clin Infect Dis 2000; 31: 1012-7.
3. Castagliuolo I, LaMont JT, Nikulasson ST, Pothoulakis C. Saccharomyces boulardii protease inhibits Clostridium difficile toxin A effects in the rat ileum. Infect Immun 1996; 64: 5225-32.
4. Van der Waaij D, Hofstra H, Wiegersma N. Effect of β-lactam antibiotics on the resistance of the digestive tract of mice to colonization. J Infect Dis 1982; 146: 417-22.
5. Orrhage K, Nord CE. Influences on the normal microbial flora. In: Elmer GW, McFarland LV, Surawicz CM, eds. Biotherapeutic Agents and Infectious Diseases. Totowa, NJ: Humana Press, 1999: 85-120.
6. Sambol SP, Merrigan MM, Tang JK, Johnson S, Gerding DN. Colonization for the prevention of Clostridium difficile disease in hamsters. J Infect Dis 2002; 186: 1781-9.
7. Toothaker RD, Elmer GW. Prevention of clindamycin induced mortality in hamsters by Saccharomyces boulardii. Antimicrob Agents Chemother 1984; 26: 552-6.
8. Lusk RH, Fekety R, Silva J, Browne RA, Ringler DH, Abrams GD. Clindamycin-induced enterocolitis in hamsters. J Infect Dis 1978; 137: 464-75.
9. Hagen CA, Shefner AM, Ehrlich R. Intestinal microflora of normal hamsters. Lab Anim Care 1965; 15: 185-93.
10. Heimdahl A, Nord CE. Effect of erythromycin and clindamycin on the indigenous human anaerobic flora and new colonization of the gastrointestinal tract. Eur J Clin Microbiol 1982; 1: 38-48.
11. Pechere JC. Lincosamides. Pathol Biol (Paris) 1986; 34: 119-28.
12. Bartlett JG. Antibiotic-associated diarrhea. Clin Infect Dis 1992; 15: 573-7.
13. Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, Van Belle G. Prevention of antibiotic-associated diarrhea by S. boulardii: a prospective study. Gastroenterology 1989; 96: 981-8.
14. Gedek BR. Adherence of Escherichia coli serogroup O 157 and the Salmonella typhimurium mutant DT 104 to the surface of Saccharomyces boulardii. Mycoses 1999; 42: 261-4.
15. Tasteyre A, Barc MC, Karjalainen T, Bourlioux P, Collignon A. Inhibition of in vitro cell adherence of Clostridium difficile by Saccharomyces boulardii. Microb Pathog 2002; 32: 219-25.